SAT-080 An Atypical Adenoma Presenting with Hyperandrogenism: A Rare Case Presentation on a Pituitary Germ Cell Tumor

Abstract Disclosure: D.H. Tran: None. C. Pham: None. J.D. Carmichael: None. G. Zada: None. J. Sisti: None. D. Ashouri: None. C.T. Nguyen: None. Background: Mixed germ cell tumors (GCT) are a rarely reported etiology for pituitary masses. Clinical Case: An 18-year-old-male with no medical history and normal pubertal development presented with one year of progressive bilateral vision loss and persistent headaches. MRI demonstrated 33x18x30 mm macroadenoma with optic chiasm compression. He reported gynecomastia, galactorrhea, frontal hair loss, weight gain, fatigue, and coarsening skin. He denied loss of libido, excessive thirst, polyuria, or illicit androgen use. Initial lab results demonstrated total testosterone 805 ng/dL (249-836), free testosterone 39.55 ng/dL (8.30-25.70), FSH 0.56 mIU/mL (1.4-18.1), LH <0.07 mIU/mL (<6.00), prolactin 63.77 ng/mL (2.17-17.7), AM cortisol 1.69 mcg/dL (5.27-22.45), free T4 0.53 ng/dL (0.89-1.76), and TSH 0.13 mIU/L (0.55-4.78). Physical exam revealed male pattern baldness, acne, bilateral gynecomastia, and Tanner stage V genital development without atrophic testes (estimated 15-20 cc) concerning for hyperandrogenism. Patient underwent resection of the pituitary mass. Post-operative course was complicated by arginine vasopressin deficiency (AVP-D). Pathology demonstrated a pleomorphic and cystic mixed GCT (70% teratoma, 25% seminoma, 5% choriocarcinoma), with human chorionic gonadotropin (hCG) 28.9 mIU/mL (<5), alpha fetoprotein (AFP) <1.8 ng/mL (<8.3), and alkaline phosphatase (ALP) 76U/L (46-169). Immunohistochemistry findings showed Sal-like protein 4 (SALL4) expression of the seminomatous and choriocarcinoma components and octamer 4 (OCT4) of the seminomatous components, which are highly specific markers for seminomas. The patient was discharged home on hormonal replacement and referred to oncology for further therapies. Conclusion: This case highlights a rare manifestation of mixed GCT of the pituitary with hyperandrogenism. GCTs can be divided into germinomas or non-germinomas and mostly present in males with a higher incidence in Asians. More than half present in the first decade of life with a median age of 16. Many patients experience precocious puberty and rapid vision loss with associated AVP-D. Associated markers include elevated HCG, AFP, and placental ALP in germinomas. First line treatment includes radiotherapy with adjuvant treatment including platinum-based chemotherapy regimens. This case highlights how careful physical examination and interpretation of endocrine hormones can help elucidate the source of hormonal dysfunction, and that atypical findings should prompt further evaluation and a broad differential diagnosis. Presentation: Saturday, July 12, 2025

Authors

Institutions

Publication Details

Journal
Journal of the Endocrine Society
Published
2025-10-01
DOI
https://doi.org/10.1210/jendso/bvaf149.1562
Primary Topic
Testicular diseases and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SAT-080 An Atypical Adenoma Presenting with Hyperandrogenism: A Rare Case Presentation on a Pituitary Germ Cell Tumor

Caroline T. Nguyen, John D. Carmichael, Christopher Pham, Diana Ashouri et al.
Journal of the Endocrine Society
Testicular diseases and treatments
article

SAT-080 An Atypical Adenoma Presenting with Hyperandrogenism: A Rare Case Presentation on a Pituitary Germ Cell Tumor

Caroline T. Nguyen, John D. Carmichael, Christopher Pham, Diana Ashouri, Deanna Tran, Jonathan Sisti, Gabriel Zada
article en

Abstract

Abstract Disclosure: D.H. Tran: None. C. Pham: None. J.D. Carmichael: None. G. Zada: None. J. Sisti: None. D. Ashouri: None. C.T. Nguyen: None. Background: Mixed germ cell tumors (GCT) are a rarely reported etiology for pituitary masses. Clinical Case: An 18-year-old-male with no medical history and normal pubertal development presented with one year of progressive bilateral vision loss and persistent headaches. MRI demonstrated 33x18x30 mm macroadenoma with optic chiasm compression. He reported gynecomastia, galactorrhea, frontal hair loss, weight gain, fatigue, and coarsening skin. He denied loss of libido, excessive thirst, polyuria, or illicit androgen use. Initial lab results demonstrated total testosterone 805 ng/dL (249-836), free testosterone 39.55 ng/dL (8.30-25.70), FSH 0.56 mIU/mL (1.4-18.1), LH <0.07 mIU/mL (<6.00), prolactin 63.77 ng/mL (2.17-17.7), AM cortisol 1.69 mcg/dL (5.27-22.45), free T4 0.53 ng/dL (0.89-1.76), and TSH 0.13 mIU/L (0.55-4.78). Physical exam revealed male pattern baldness, acne, bilateral gynecomastia, and Tanner stage V genital development without atrophic testes (estimated 15-20 cc) concerning for hyperandrogenism. Patient underwent resection of the pituitary mass. Post-operative course was complicated by arginine vasopressin deficiency (AVP-D). Pathology demonstrated a pleomorphic and cystic mixed GCT (70% teratoma, 25% seminoma, 5% choriocarcinoma), with human chorionic gonadotropin (hCG) 28.9 mIU/mL (<5), alpha fetoprotein (AFP) <1.8 ng/mL (<8.3), and alkaline phosphatase (ALP) 76U/L (46-169). Immunohistochemistry findings showed Sal-like protein 4 (SALL4) expression of the seminomatous and choriocarcinoma components and octamer 4 (OCT4) of the seminomatous components, which are highly specific markers for seminomas. The patient was discharged home on hormonal replacement and referred to oncology for further therapies. Conclusion: This case highlights a rare manifestation of mixed GCT of the pituitary with hyperandrogenism. GCTs can be divided into germinomas or non-germinomas and mostly present in males with a higher incidence in Asians. More than half present in the first decade of life with a median age of 16. Many patients experience precocious puberty and rapid vision loss with associated AVP-D. Associated markers include elevated HCG, AFP, and placental ALP in germinomas. First line treatment includes radiotherapy with adjuvant treatment including platinum-based chemotherapy regimens. This case highlights how careful physical examination and interpretation of endocrine hormones can help elucidate the source of hormonal dysfunction, and that atypical findings should prompt further evaluation and a broad differential diagnosis. Presentation: Saturday, July 12, 2025

Journal of the Endocrine SocietyVol. 9(Supplement_1)
Keck Hospital of USC (US)
Openalex Percentile: Top 52%
Testicular diseases and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.